NUR-SULTAN – The Polpharma Group, one of the top 20 leading manufacturers of generic medications globally, has been making a significant contribution to the pharmaceutical industry’s development in Kazakhstan. The company’s input has demonstrated its vital role in the country during the pandemic.
President of the Polpharma Supervisory Board Jerzy Starak spoke about the company’s projects in the country and its development plans in a recent interview with The Astana Times.
Last year marked the 10th anniversary of the company’s partnership with Kazakhstan. Could you tell us about the major achievements over the last 10 years of the company’s activities in the country?
It was a truly remarkable period, remembered for a real breakthrough in the development of the pharmaceutical industry of Kazakhstan. In 2011, SANTO Member of the Polpharma Group with the Chimpharm…